Abbott Laboratories buy Daiwa Capital Markets
Start price
21.10.25
/
50%
€110.72
Target price
21.10.26
€116.80
Performance (%)
-11.09%
Price
27.02.26
€98.44
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.09%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 3.393% | 3.393% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Daiwa Capital Markets from $134.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Daiwa_Capital_Market for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€92.30
31.01.26
31.01.26
€95.29
31.01.27
31.01.27
6.65%
27.02.26
27.02.26
